Braun Stacey Associates’s C.H. Robinson CHRW Stock Holding History

Braun Stacey Associates’s Portfolio CHRW Stock Details CHRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-19,300	Closed	-$1.2M	–	165
2015 Q2	$1.2M	Buy	+19,300	New	+$1.27M	0.05%	186

Other funds holding CHRW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YAM

Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Braun Stacey Associates's CHRW Position: Q3 2015 in Review

Braun Stacey Associates sold out of C.H. Robinson (CHRW) in Q3 2015, closing a stake of 19,300 shares — an estimated $1.2M sold.

Braun Stacey Associates first reported a position in CHRW in Q2 2015 and held it in 1 quarter. The position peaked at $1.2M in Q2 2015. 458 funds tracked by Wall St. Rank hold CHRW as of Q3 2015.

Braun Stacey Associates reported no remaining C.H. Robinson position as of Q3 2015 after selling out during the quarter.
Braun Stacey Associates sold 19,300 C.H. Robinson shares in Q3 2015, an estimated $1.2M.
Braun Stacey Associates first reported a position in C.H. Robinson in Q2 2015 and held it in 1 quarter.
Braun Stacey Associates's C.H. Robinson position peaked at $1.2M in Q2 2015.
458 funds tracked by Wall St. Rank held C.H. Robinson as of Q3 2015.

Based on Braun Stacey Associates's 13F filing for Q3 2015, filed 1 Dec 2015.